Experts believe a wider spat with Europe would be much more damaging than the current tit-for-tat with China.Traderead more
After the Fed released minutes of its last meeting, the bond market signaled it fears the Fed will not be aggressive enough with its rate cutting.Market Insiderread more
The Fed minutes also note that "a couple" members wanted a 50 basis point cut, based primarily on the weak inflation readings.The Fedread more
Markets pay particular attention to Italy's spending, given its public debt pile. This stands at above 130% of its growth rate, one of the highest in the world.Politicsread more
Flight bookings to Hong Kong have fallen 10%, hit by the unrest in the city, said Alan Joyce, the chief executive of Australian carrier Qantas Airways.Airlinesread more
Analysts generally doubt how effective the People Bank of China's latest interest rate announcement will be in significantly helping businesses grow.China Economyread more
These in-demand skills can command top pay packets, says Feon Ang of professional networking site LinkedIn.Get Aheadread more
Japanese manufacturing activity shrank for a fourth straight month in August as export orders fell at a sharper pace.Asia Marketsread more
The Washington governor had centered his campaign around climate change, calling it "the most urgent challenge of our time."Politicsread more
The inversion is seen by many veteran traders as an important recession omen, though the timing on the eventual downturn is less predictable.Bondsread more
Here's what Nordstrom reported for its fiscal second-quarter earnings.Retailread more
Take a look at some of Wednesday's midday movers:
ConAgra Foods - The maker of Hunt's tomato ketchup and Slim Jim beef jerky fell sharply after estimating an adjusted quarterly profit below its forecast.
Endocyte - The drug developer fell after saying Merck would no longer pursue the development of its cancer drug.
EnteroMedics - The company climbed after saying an FDA panel voted in favor of its obesity device.
Foresight Energy - The company fell in its market debut after pricing 17.5 million shares at $20 apiece.
General Electric - The conglomerate fell after Reuters cited a source in saying GE would make an improved offer for the energy unit of France's Alstom on Thursday.
General Motors - The automaker declined after being hit with a $10 billion lawsuit saying ignition switch recalls damaged the brand. Members of a House panel on Wednesday grilled GM CEO Mary Barra on the recall and defective switches blamed for at least 13 deaths.
GW Pharmaceuticals - The drug developer fell on its plants to sell 1.7 million ADR shares in a public offering.
Insmed - The biopharmaceutical soared after the Food and Drug Administration granted Breakthrough Therapy status to the company's only drug candidate, an inhaled antibiotic for lung infections.
Nokia - The Finnish telecom equipment company gained after it said it plans to buy back up to 370 million of its shares.
Public Service Enterprise Group - The utility and others including Northeast Utilities, Integrys Energy Group, AES and Sempra Energy moved higher as the Dow Jones Utility Index hit an intraday record high.
Shire - The biopharmaceutical company gained following a SunTrust note suggesting Allergan could bid for the company. Valeant Pharmaceuticals on Wednesday said it had launched a $53 billion hostile offer for Allergan, the maker of Botox.
Viper Energy Partners - The developer of oil and natural-gas properties jumped in its market debut after pricing 5 million shares at $26 a share.
Walgreen - The drugstore chain advanced after Barclays Capital raised its rating to overweight from equal weight.
Yelp - The online directory of local businesses rose after saying on its blog that users will now be able to message businesses directly.
ZS Pharma - The development stage biopharmaceutical company surged in its market debut after pricing nearly 6 million shares at $18 a share.
(Read More: )
—By CNBC's Rich Fisherman.
Questions? Comments? Email us at firstname.lastname@example.org